Laperrouze J. (2021) How Non-Animal Testing Can Reshape Health and Environment Policies. Vox Europ link 

Lauschke K, Treschow AF, Rasmussen MA, Davidsen N, Holst B, Emnéus JK, Taxvig C and Vinggaard AM (2021) Creating a human NKX2.5 reporter stem cell line for developmental toxicity testing. Arch Toxicol p.1-12 doi: 10.1007/s00204-021-03018-y   

Lauschke K, Volpini L, Liu Y, Vinggaard AM, Hall VJ (2021) A comparative assessment of marker expression between cardiomyocyte differentiation of human iPSCs and the developing pig heart. Stem Cells Dev 30(7):374-385 doi: 10.1089/scd.2020.0184   

Rodríguez-Carrillo A, Rosenmai AK, Mustieles V, Couderq S, Fini J-B, Vela-Soria F, Molina-Molina JM, Ferrando-Marco P, Bonefeld-Jorgensen EC, Olea N, Vinggaard AM, Fernández MF (2021) Assessment of chemical mixtures using biomarkers of combined biological activity: Screening study with human placentas. Reprod Toxicol 100:143-154 doi: 10.1016/j.reprotox.2021.01.002   

Weber T, Wirths F, Brakebusch N, van der Valk J (2021) Reply to comment ‘Animal welfare and ethics in the collection of fetal blood for the production of fetal bovine serum’, ALTEX 38(2): 324-326 doi: 10.14573/altex.2103191